1. Home
  2. CDNA vs QURE Comparison

CDNA vs QURE Comparison

Compare CDNA & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$27.77

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$49.47

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
QURE
Founded
1998
1998
Country
United States
Netherlands
Employees
N/A
248
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2007
2013

Fundamental Metrics

Financial Performance
Metric
CDNA
QURE
Price
$27.77
$49.47
Analyst Decision
Buy
Buy
Analyst Count
6
14
Target Price
$28.00
$45.00
AVG Volume (30 Days)
866.7K
2.6M
Earning Date
04-28-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.67
EPS
0.05
N/A
Revenue
$48,324,000.00
$13,107,000.00
Revenue This Year
$16.01
$126.12
Revenue Next Year
$11.31
$200.43
P/E Ratio
$557.00
N/A
Revenue Growth
18.93
N/A
52 Week Low
$10.96
$8.73
52 Week High
$28.42
$71.50

Technical Indicators

Market Signals
Indicator
CDNA
QURE
Relative Strength Index (RSI) 71.83 77.74
Support Level $14.59 $21.63
Resistance Level N/A $60.70
Average True Range (ATR) 1.39 2.73
MACD 0.39 2.11
Stochastic Oscillator 92.28 96.03

Price Performance

Historical Comparison
CDNA
QURE

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: